My Recent Searches
- No Recent Search.
My Tests Viewed
- No Test Viewed.
BRCAvantage®, Ashkenazi Jewish Screen w/Reflex BRCAvantage®, Comprehensive
Physician Attestation of Informed Consent
This germline genetic test requires physician attestation that patient consent has been received if ordering medical facility is located in AK, DE, FL, GA, IA, MA, MN, NV, NJ, NY, OR, SD or VT or test is performed in MA.
This reflexive test screens for 3 mutations within BRCA1 and BRCA2 that are commonly found in the Ashkenazi Jewish population. If the results are negative, the test will reflex to comprehensive testing of the BRCA1 and BRCA2 genes through sequencing and deletion/duplication analysis.
If BRCAvantage® Ashkenazi Jewish Screen is negative, BRCAvantage®, Comprehensive will be performed at an additional charge (CPT code(s): 81162).
Fluorescent Polymerase Chain Reaction • Next Generation Sequencing with Microarray confirmation
See Laboratory Report
To view specimen requirements and codes please Select a regional laboratory.
Not sure which laboratory serves your office? Call us 866-MYQUEST (866-697-8378)
Reference ranges are provided as general guidance only. To interpret test results use the reference range in the laboratory report.
The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
* The tests listed by specialist are a select group of tests offered. For a complete list of Quest Diagnostics tests, please refer to our Directory of Services.